Author： Prakash A. Perry C.M.
Publisher： Adis International
ISSN： 1175-3277
Source： American Journal of Cardiovascular Drugs, Vol.2, Iss.5, 2002-01, pp. : 335-343
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Mathier Michael A Ishizawar David
Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. :
Access to resources
Recommend
By Breu V. Ertel S.I. Roux S. Clozel M.
Expert Opinion on Investigational Drugs, Vol. 7, Iss. 7, 1998-07 ,pp. :
Bosentan: Hepatotoxicity: case report
Reactions Weekly, Vol. 1, Iss. 1092, 2006-01 ,pp. :
Bosentan: A Viewpoint by Lewis J. Rubin
By Rubin L.J.
American Journal of Cardiovascular Drugs, Vol. 2, Iss. 5, 2002-01 ,pp. :
Bosentan potentially cost effective in PAH
Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. :